primarily on social and differential aspects, as well as possible psychopathological elements. These endeavours have led to reports of significant associations between schizotypal facets (odd or magical thinking and, to a lesser extent, ideas of references) and the endorsement of conspiracist beliefs. However, one limitation of extant findings is the assumption that the aforementioned relationships are ultimately direct; that is, schizotypal facets are directly associated with conspiracist beliefs, rather than influenced by mediating processes. To overcome this limitation, the present study sought to replicate previous findings by confirming the relationships between components of schizotypy and conspiracist beliefs. Second, this study examined the mediating influence of cognitive processes on this relationship. Methods: An international online sample of 411 women and men completed measures of schizotypal components (i.e., odd beliefs or magical thinking and ideas of reference), conspiracist beliefs, and cognitive processes (i.e., need for cognition, analytic thinking, and cognitive insight).
primarily on social and differential aspects, as well as possible psychopathological elements. These endeavours have led to reports of significant associations between schizotypal facets (odd or magical thinking and, to a lesser extent, ideas of references) and the endorsement of conspiracist beliefs. However, one limitation of extant findings is the assumption that the aforementioned relationships are ultimately direct; that is, schizotypal facets are directly associated with conspiracist beliefs, rather than influenced by mediating processes. To overcome this limitation, the present study sought to replicate previous findings by confirming the relationships between components of schizotypy and conspiracist beliefs. Second, this study examined the mediating influence of cognitive processes on this relationship. Methods: An international online sample of 411 women and men completed measures of schizotypal components (i.e., odd beliefs or magical thinking and ideas of reference), conspiracist beliefs, and cognitive processes (i.e., need for cognition, analytic thinking, and cognitive insight). Results: Through path analysis, results indicated associations between both schizotypal facets and conspiracist beliefs in the present sample. Further, there was evidence for the association between analytic thinking and conspiracist beliefs, and between cognitive insight and conspiracist beliefs. Indeed, cognitive insight was found to mediate the association between odd beliefs or magical thinking and ideas of reference with conspiracist beliefs. In addition, analytic thinking provided a mediating link to conspiracy ideation for odd beliefs or magical thinking, this was not found with ideas of reference. Despite an association between odd beliefs or magical thinking and need for cognition, this did not extend to conspiracist beliefs. Discussion: In summary, the results of this study supported the association between schizotypal components and conspiracist beliefs. However, they also extend previous research by suggesting that cognitive processes mediate this link. That is, although a direct link between these variables may be tenable, it is also important to consider the possible ways in which schizotypy influences cognitive processes, which in turn have an effect on conspiracist beliefs. From a practical point-of-view, this highlights possible intervention routes for reducing conspiracist beliefs, either by targeting schizotypal traits indirectly or cognitive factors directly. While this research addresses schizotypy, patients with psychotic disorders and those with an at-risk mental state have also been shown to have reasoning biases. Therefore, future research, in relation to the clinical spectrum, should consider not only reasoning biases, but an outcome of conspiracy beliefs. Background: Negative symptoms and depression have in many studies been found to be moderately associated, and when present, it reflects negative symptoms of a secondary nature. Primary negative symptoms are thought to be intrinsic to schizophrenia, while secondary to be caused by depression, positive symptoms and medication side effects. Instability in above associations over time is also considered to reflect a secondary origin. Despite the clinical importance of secondary negative symptoms little research has focused on what is their underlying nature. Especially apathy and depression have common clinical features and are often found to correlate. Apathy and depression are self-perceived states and self-reports could add to our understanding. Studying the underlying themes of associations between apathy and depression as well as stability over time could therefore add to the current understanding of the primary or secondary nature of negative symptoms. Methods: Eighty-four first episode psychosis patients from TOP/ NORMENT study in Oslo, Norway were assessed at baseline and 1-year follow-up with the Calgary Depression Scale (CDSS), Apathy Evaluation Scale (AES), both self-report (AES-S) and clinician (AES-C), and the Positive and Negative Symptoms Scale (PANSS). Correlation with total scale, individual scale items and linear regression was used to study associations and explained variance over time. Results were repeated controlling for positive symptoms and excluding those with high level of depression. Results: CDSS and AES correlated at the 0.4 to 0.5 levels at both baseline and follow up, regardless of AES-S or AES-C. Hopelessness and feeling of depression were the CDSS items with stable and concurrent correlation strength to AES-S and AES-C. For CDSS, we found correlation of equal strength and stability to the AES-S-and AES-C items of getting things done during the day, spending time on interests, getting excited and taking initiative. Same significant correlations to CDSS were found for PANSS amotivation factor, but not for PANSS expressive factor. Controlling for PANSS positive symptoms did not change results, and excluding those with high levels of depression only mildly changed results. Discussion: This study shows a significant correlation between apathy and depression that is stable over time for the full scale and also at the item level, regardless of self-reporting or clinician assessed apathy. Underlying themes of the concurrent correlation reflect lack of initiative and hopelessness and are in line with the defeatist beliefs found to correlate with negative symptoms, mediate between motivation and reduced effort and have recently been a target for cognitive remediation therapy. This study does not give an answer to a primary or secondary origin of apathy, but the stability points more to an underlying common nature than one being the cause of the other. Background: Dopamine and serotonin neurotransmission relies mostly on the action of four factors: serotonin and dopamine transporters (SERT and DAT) and enzymes monoaminooxidase A (MAO-A) and catechol-O-mehtyltransferase (COMT). The goal of this research was to closely examine schizophrenia symptom domains in relation to the investigated polymorphisms. Methods: Study group was composed of 300 schizophrenic patients. Severity of schizophrenia was assessed by the Positive and negative syndrome scale (PANSS), depressive symptoms were assessed with Calgary depression scale for schizophrenia (CDSS). SERT (5-HTTLPR), DAT (VNTR), COMT (Val158Met) and MAO-A (VNTR) gene polymorphisms were analyzed. Schizophrenia symptom dimensions were determined with multivariate statistical methods, while logistic regression and ANOVA were used to investigate the influence of a genotype on a symptom domain.
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Results: Factor analysis of PANSS scale retained all 30 items and identified 5 separate factors (aggressive/impulsive, affective/depressive, cognitive, negative and positive symptoms). Analysis of CDSS scale revealed 2 separate factors (depression and suicidality). Statistically significant PANSS variables were those of aggressive/impulsive and negative symptoms, while suicidality was the only significant CDSS variable. Discussion: Our PANSS scale factor analysis established 5 distinct factors. Previous factor analyses provided from 3, up to 7 different factors, but mostly 5 distinct ones: negative symptoms, positive symptoms, depressive symptoms, excitement and disorganization. That factor distribution corresponds to our findings in terms of identified number of factors, but seems to differ in terms of item distribution within those factors. When testing the influence of investigated gene polymorphisms on the variable of total PANSS score and five distinct factors we did not establish significant findings regarding four variables: total PANSS score, positive, cognitive and affective/depressive symptoms. While that is in line with majority of other investigations, SERT promoter polymorphism and COMT Val158Met gene polymorphism have been previously associated with depressive and positive symptoms. SERT and MAO-A polymorphisms separately had a significant effect on the variable of aggressive/impulsive symptoms, which has not been reported earlier. Furthermore, significant influence of COMT gene polymorphism was established for the variable of negative symptoms, which is a confirmation of some earlier reports, although there have been contrary findings. Previous reports of CDSS scale factor structure are limited to data from its initial validation to the few recent findings of its three-factor structure (depression, cognition and melancholy). We identified 2 separate factors using factor analysis, "depression" (which included seven out of nine items) and "suicidality". To the best of our knowledge this is the first investigation of the putative association between any of the four investigated polymorphisms and depressive symptoms of schizophrenia measured by the CDSS scale. Ultimately, we did not establish a significant association of investigated gene polymorphisms and total CDSS score, as well as the "depression" factor. However, there was a significant association between the "suicidality" factor and SERT and MAO-A gene polymorphisms, as well as their interaction. The fact that the significant association was established for only one of the two obtained CDSS factors suggests that the association is subtle and, at least partially, explains rarely reported associations between investigated gene polymorphisms and schizophrenia symptom domains, which is especially true for depressive symptomatology. Background: Anxiety and depressive symptoms and psychotic experiences constitute common features of emerging mental disorders in young people. Psychotic experiences and the ultra-high risk (UHR) state for psychosis appear to have a particular importance for clinical presentation, progression of symptomatology, quality of life and functioning, but the impact of psychotic experiences in individuals seeking help at non-UHR services, compared to UHR services, is under-researched. Methods: 69 young people (Mage ± SD at baseline = 20.8 ± 2.6, range 16-26 years, 48 females) presenting to mental health services were grouped according to UHR and non-UHR status. They were assessed at baseline for psychotic experiences, anxiety and depressive symptoms, psychological distress, psychosocial functioning and quality of life. They were followed up at three, six, and 12 months. Data were analysed using mixed and general linear modelling. Results: UHR individuals reported higher levels of depressive symptoms and lower levels of role functioning at baseline compared to non-UHR individuals. Significant differences were evident over time for psychological distress and quality of life, with greater impairment developing in those at UHR. No robust differences were reported for anxiety symptoms or social functioning. Discussion: Psychotic experiences appear to be particularly associated with depressive symptoms and psychological distress, impaired role functioning and quality of life in help-seeking young people in the medium-term. It is therefore important to pay special attention to psychotic experiences in the early stages of mental health problems even if psychotic symptoms are not the main motivation for help-seeking.
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